✦ LIBER ✦

PP-119 Lamivudine in hepatitis B reactivation in patients with rheumatologic diseases on chronic immunosuppression

✍ Scribed by M.E. Velasquez; A. Salvana; E. Tripon; E.L. Ang; N. Estanislao IV; H. Flores; V. Banez; J. Ong

Book ID: 118617521
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 43 KB
Volume: 14
Category: Article
ISSN: 1201-9712
DOI: 10.1016/s1201-9712(10)60187-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1494 Viral clearance, lamivudine resist

P1494 Viral clearance, lamivudine resistant mutants appearance and HBV reactivation in patients with chronic hepatitis B in end-stage renal disease treated with lamivudine

✍ Telehin, D.; Tychka, I.; Lulchuk, M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Immunosuppressive effect of IDO on T cel

Immunosuppressive effect of IDO on T cells in patients with chronic hepatitis B

✍ Yong-bing Chen; Si-dan Li; Yi-ping He; Xian-jie Shi; Yong Chen; Jian-ping Gong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

PP-094 Influential factors of prognosis

PP-094 Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

✍ L.-J. Sun; J.-W. Yu; P. Kang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Antiviral activity and safety of LB80380

Antiviral activity and safety of LB80380 in hepatitis B e antigen–positive chronic hepatitis B patients with lamivudine-resistant disease

✍ Man-Fung Yuen; Kwang-Hyub Han; Soon-Ho Um; Seung Kew Yoon; Hye-Ryon Kim; John Ki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 1 views

We aimed to determine the antiviral activity and safety of a new nucleotide analogue, LB80380, in chronic hepatitis B (CHB) patients with lamivudine-resistant virus. Sixty-five patients with lamivudine-resistant virus were randomized to receive five ascending daily doses (30, 60, 90, 150, 240 mg) of

Clinical reactivation during lamivudine

Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis

✍ A. MARRONE; R. ZAMPINO; P. KARAYANNIS; G. CIRILLO; G. CESARO; B. GUERRERA; R. RI 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

Effect of lamivudine on morphology and f

Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B

✍ P Honkoop; R A De Man; H R Scholte; P E Zondervan; J W Van Den Berg; L H Rademak 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

Nucleoside analogues can induce mitochondrial dysfunction leading to severe clinical syndromes. Lamivudine, a new nucleoside analogue, is an active inhibitor of hepatitis B viral replication without apparent clinical toxicity. To assess subclinical mitochondrial toxicity, we studied the morphology a